Alembic Pharmaceuticals has received final approval from the US Food Drug Administration USFDA for its Abbreviated New Drug Application ANDA Nifedipine Extended-Release Tablets USP 30 mg 60 mg and 90 ...
ADALAT® XL® (nifedipine extended-release tablets) first received market authorization in Canada in 1995 and is indicated for the management of chronic stable angina and the management of mild to ...
High-dose calcium channel blocker (CCB) shows strong blood pressure (BP) lowering effect. Currently available of controlled-release (CR) nifedipine 80 mg per day clinical data are limited to ...
ADALAT ® XL ® (nifedipine extended-release tablets) first received market authorization in Canada in 1995 and is indicated for the management of chronic stable angina and the management of mild to ...
From Left to right: Olenka Crewe, VP of Business Development & Scientific Affairs, Mint Pharmaceuticals, Jaiveer Singh, CEO Mint Pharmaceuticals, Viktoria Friedrich, Country President and General ...
MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Bayer Canada is pleased to announce a new partnership with Mint Pharmaceuticals Inc. for the distribution of ADALAT ® XL ® 30 mg tablets 1 in Canada. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results